Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 110-121

  Casale, Thomas B ^a,e   Bernstein, I Leonard ^b   Busse, William W ^c   LaForce, Craig F ^b   Tinkelman, David G ^b   Stoltz, Randall R ^b   Dockhorn, Robert J ^b   Reimann, James ^d   Su, John Q ^d   Fick Jr , Robert B ^d   Adelman, Daniel C ^d  

^a UNIVERSITY OF IOWA   (United States)

^b University of Wisconsin ^*

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d GENENTECH INC   (United States)

^e Nebraska Medical Research Institute   (United States)

Author keywords

Allergy; Anti IgE; Antibodies; IgE

Indexed keywords

IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY;

ADULT; ALLERGIC RHINITIS; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RAGWEED; SCORING SYSTEM;

EID: 0030853854     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70202-1     Document Type: Article

References (13)

1. Kaliner M, Lemanske R. Rhinitis and asthma. JAMA 1992;68:2807-29
2. Naclerio R. Allergic rhinitis [review]. N Engl J Med 1991;325:860-9.
3. Evans R III. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis. In: Middleton E Jr, Reed CE, Ellis EF, Atkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St. Louis: Mosby; 1993. p. 1109-36.
4. Ito K, Nakagawa T, Morita Y, Okudaira H, Takaishi T, Ishii A, et al. Immunologic analysis of steroid-dependent asthma. Ann Allergy 1989;62:15-20.
5. Kemp J. New drugs in the treatment of asthma. Immunol Allergy Clin North Am 1991;11:233-49.
6. Bahna S. A 21-year salute to IgE. Ann Allergy 1989;62:471-5.
7. Presta LG, Lahr SJ, Shields RL, Porter JP, Gorman CM, Fendly BM, et al. Humanization of an antibody directed against IgE. J Immunol 1993;151:2623-32.
8. Shields R, Whether WR, Zioncheck K, O'Connell L, Fendly B, Presta LG, et al. Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 1995;107:308-12.
9. Baselga J, Tripathy D, Mendelsohn J, Benz C, Dantis L, Moore J, et al. Phase II study of recombinant human anti-HER2 monoclonal antibody (rhumAb HER2) in stage IV breast cancer (BC): HER2-shedding dependent pharmacokinetics and antitumor activity [abstract]. Proc Am Soc Clin Oncol 1995;14:103.
10. Saban R, Haak-Frendscho M, Zine M, Ridgway J, Gorman C, Presta LG, et al. Human Fc ERI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. J Allergy Clin Immunol 1994;94:836-43.
11. Juniper E, Guyatt G. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
12. Haak-Frendscho M, Ridgway J, Shields R, Robbins K, German C, Jardieu P. Human IgE receptor α-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo. J Immunol 1993;151:351-8.
13. Froehlich J, Schoenhoff M, Jardieu P, Ruppel J, Fei D, Buckley P, et al. Multiple doses of a recombinant humanized monoclonal anti-IgE antibody are safely tolerated and decrease free serum IgE to undetectable levels [abstract]. J Allergy Clin Immunol 1995;95:356.